Literature DB >> 23348014

Biological rhythms and melatonin in mood disorders and their treatments.

Laurence Lanfumey1, Raymond Mongeau, Michel Hamon.   

Abstract

Affective disorders such as major depression, bipolar disorders and seasonal affective disorders have been described as alterations of various neuronal systems. In addition to the classical monoaminergic hypotheses that have been long proposed to explain the pathophysiology of these disorders, a strong association between circadian rhythms and mood regulation has been suggested in the light of several clinical and preclinical findings. In this review, we summarize the different hypotheses on pathophysiology mechanisms underlying depressive disorders and put a special emphasis on the alterations of melatonin secretion and associated changes in biological rhythms that characterize mood disorders. Causal relationships between alterations in circadian rhythms and mood disorders are strongly supported by the antidepressant efficacy of innovative pharmacological treatments aimed at resynchronizing endogenous rhythms in depressed patients. Genetic, epigenetic and environmental factors generating desynchronization between endogenous biological rhythms and exogenous rhythms driven by environmental and societal constraints are very probably involved in the vulnerability to mood disorders. Further investigations of the molecular/cellular bases of the relationships between stress axis dysfunctions, endogenous biological rhythm dysregulations and associated functional and anatomical brain alterations should allow important progress in the knowledge of pathophysiological mechanisms of affective disorders and the downstream development of innovative, more effective and better tolerated, therapies.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348014     DOI: 10.1016/j.pharmthera.2013.01.005

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  26 in total

1.  Antepartum depression severity is increased during seasonally longer nights: relationship to melatonin and cortisol timing and quantity.

Authors:  Charles J Meliska; Luis F Martínez; Ana M López; Diane L Sorenson; Sara Nowakowski; Daniel F Kripke; Jeffrey Elliott; Barbara L Parry
Journal:  Chronobiol Int       Date:  2013-09-03       Impact factor: 2.877

2.  How to fix a broken clock.

Authors:  Analyne M Schroeder; Christopher S Colwell
Journal:  Trends Pharmacol Sci       Date:  2013-10-10       Impact factor: 14.819

3.  Potential Mechanisms of COVID-19-Related Psychological Problems and Mental Disorders.

Authors:  Alfred Shaw
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis.

Authors:  Simone Kern; Michael Geiger; Madlen Paucke; Alina Kästner; Katja Akgün; Tjalf Ziemssen
Journal:  J Mol Med (Berl)       Date:  2019-08-30       Impact factor: 4.599

Review 5.  Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system.

Authors:  Mark A Oldham; Domenic A Ciraulo
Journal:  Chronobiol Int       Date:  2014-01-07       Impact factor: 2.877

Review 6.  Clinical pharmacology of melatonin in the treatment of tinnitus: a review.

Authors:  Marco Miroddi; Rocco Bruno; Francesco Galletti; Fabrizio Calapai; Michele Navarra; Sebastiano Gangemi; Gioacchino Calapai
Journal:  Eur J Clin Pharmacol       Date:  2015-01-20       Impact factor: 2.953

7.  Sleep & Circadian Health are Associated with Mood & Behavior in Adolescents with Overweight/Obesity.

Authors:  Stacey L Simon; Cecilia Diniz Behn; Andrea Laikin; Jill L Kaar; Haseeb Rahat; Melanie Cree-Green; Kenneth P Wright; Kristen J Nadeau
Journal:  Behav Sleep Med       Date:  2019-06-20       Impact factor: 2.964

Review 8.  Intracellular Signaling Cascades in Bipolar Disorder.

Authors:  Gregory H Jones; Carola Rong; Aisha S Shariq; Abhinav Mishra; Rodrigo Machado-Vieira
Journal:  Curr Top Behav Neurosci       Date:  2021

Review 9.  Agomelatine: an agent against anhedonia and abulia?

Authors:  J Thome; P Foley
Journal:  J Neural Transm (Vienna)       Date:  2013-12-06       Impact factor: 3.575

Review 10.  New Pharmacological Interventions in Bipolar Disorder.

Authors:  Mario F Juruena; Luke A Jelen; Allan H Young; Anthony J Cleare
Journal:  Curr Top Behav Neurosci       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.